Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (161-170 of 1,111) with videos related to

Pageof 112
Sort By:
Archives of Cardiovascular Diseases|August 18, 2014
Management of outpatients in France with stable coronary artery disease. Findings from the prospeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease (CLARIFY) registryNicolas Danchin, Jean Ferrieres, Maxime Guenoun, et al.
La Tunisie Medicale|October 26, 2012
[Clinical characteristics, management and prognostic evolution of patients admitted within six hours of symptom onset with st-segment elevation acute myocardial infarction complicated by cardiogenic shock : twenty year monocentric study]Sami Marouene, Jean Michel Juliard, Jean Louis Golmard, et al.
Heart (British Cardiac Society)|July 1, 2011
Risk factors and outcomes for patients with vascular disease and serious bleeding eventsMark J Alberts, Deepak L Bhatt, Sidney C Smith, et al.
The American Journal of Cardiology|April 26, 2015
Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials)Eric A Secemsky, Alexis Matteau, Robert W Yeh, et al.
The Canadian Journal of Cardiology|October 9, 2010
One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registryKim G Smolderen, Alan Bell, Yang Lei, et al.
Stroke|March 24, 2007
Prevalence and determinants of subdiaphragmatic visceral infarction in patients with fatal strokeHalim Abboud, Julien Labreuche, Fernando Gongora-Riverra, et al.
Heart, Lung & Circulation|March 21, 2013
Outcomes and excess costs among patients with cardiovascular diseaseZanfina Ademi, Danny Liew, Ella Zomer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 7, 2012
Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched studyMartial Hamon, Sunil V Rao, Gabriel Steg, et al.
Plos One|May 10, 2012
Heart rate and use of beta-blockers in stable outpatients with coronary artery diseasePh Gabriel Steg, Roberto Ferrari, Ian Ford, et al.
Circulation. Cardiovascular Interventions|April 16, 2015
Activated clotting time and outcomes during percutaneous coronary intervention for non-ST-segment-elevation myocardial infarction: insights from the FUTURA/OASIS-8 TrialGregory Ducrocq, Sanjit Jolly, Shamir R Mehta, et al.
Pageof 112

Showing results (161-170 of 1,111) with videos related to

Sort By:
Pageof 112
Archives of Cardiovascular Diseases|August 18, 2014
Management of outpatients in France with stable coronary artery disease. Findings from the prospeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease (CLARIFY) registryNicolas Danchin, Jean Ferrieres, Maxime Guenoun, et al.
La Tunisie Medicale|October 26, 2012
[Clinical characteristics, management and prognostic evolution of patients admitted within six hours of symptom onset with st-segment elevation acute myocardial infarction complicated by cardiogenic shock : twenty year monocentric study]Sami Marouene, Jean Michel Juliard, Jean Louis Golmard, et al.
Heart (British Cardiac Society)|July 1, 2011
Risk factors and outcomes for patients with vascular disease and serious bleeding eventsMark J Alberts, Deepak L Bhatt, Sidney C Smith, et al.
The American Journal of Cardiology|April 26, 2015
Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials)Eric A Secemsky, Alexis Matteau, Robert W Yeh, et al.
The Canadian Journal of Cardiology|October 9, 2010
One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registryKim G Smolderen, Alan Bell, Yang Lei, et al.
Stroke|March 24, 2007
Prevalence and determinants of subdiaphragmatic visceral infarction in patients with fatal strokeHalim Abboud, Julien Labreuche, Fernando Gongora-Riverra, et al.
Heart, Lung & Circulation|March 21, 2013
Outcomes and excess costs among patients with cardiovascular diseaseZanfina Ademi, Danny Liew, Ella Zomer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 7, 2012
Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched studyMartial Hamon, Sunil V Rao, Gabriel Steg, et al.
Plos One|May 10, 2012
Heart rate and use of beta-blockers in stable outpatients with coronary artery diseasePh Gabriel Steg, Roberto Ferrari, Ian Ford, et al.
Circulation. Cardiovascular Interventions|April 16, 2015
Activated clotting time and outcomes during percutaneous coronary intervention for non-ST-segment-elevation myocardial infarction: insights from the FUTURA/OASIS-8 TrialGregory Ducrocq, Sanjit Jolly, Shamir R Mehta, et al.
Pageof 112